Lifetime alcohol intake and pancreatic cancer incidence and survival: findings from the Melbourne Collaborative Cohort Study

Cancer Causes & Control : CCC
Harindra JayasekaraRobert J MacInnis

Abstract

Pancreatic cancer has one of the worst prognoses with 5-year survival below 10%. There is some evidence that alcohol consumption might increase the risk of pancreatic cancer. We examined associations of pre-diagnostic alcohol intake with (i) incidence of pancreatic cancer, and (ii) overall survival following pancreatic cancer. Usual alcohol intake was estimated at recruitment in 1990-1994 for 38,472 participants in the Melbourne Collaborative Cohort Study using recalled frequency and quantity of beverage-specific intake for 10-year periods from age 20. Pancreatic cancer incidence (C25 according to International Classification of Diseases for Oncology) and vital status were ascertained through to 30 September 2015. Cox regression was performed to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for associations with lifetime, age 20-29, and baseline alcohol intakes. By the end of follow-up (average 20.2 years), 239 incident cases of pancreatic cancer were diagnosed, of which 228 had died. No evidence of an association was observed between alcohol intake and risk of pancreatic cancer. Higher lifetime alcohol intake was associated with lower overall survival following a diagnosis of pancreatic...Continue Reading

References

Oct 5, 1988·Journal of the National Cancer Institute·F E HarrellB G Pollock
Jan 1, 1993·Medicine and Science in Sports and Exercise·B E AinsworthR S Paffenbarger
May 20, 1993·The New England Journal of Medicine·A B LowenfelsL Domellöf
Jan 1, 1997·American Journal of Epidemiology·E L KornD Midthune
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Jan 6, 2001·Cancer Causes & Control : CCC·S S CoughlinM J Thun
Oct 25, 2003·Pancreas·Mary C Dufour, Megan D Adamson
Aug 2, 2005·Alcohol·Vay Liang W GoStephen J Pandol
Sep 12, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Allison M HodgeGraham G Giles
Apr 17, 2007·The Lancet Oncology·Robert BaanUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Mar 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jeanine M GenkingerStephanie A Smith-Warner
Mar 21, 2009·American Journal of Epidemiology·Li JiaoRachael Z Stolzenberg-Solomon
Mar 26, 2009·American Journal of Epidemiology·Mirjam M HeinenPiet A van den Brandt
Apr 8, 2010·Cancer Causes & Control : CCC·Dominique S MichaudRachael Z Stolzenberg-Solomon
Mar 16, 2011·Archives of Internal Medicine·Susan M GapsturMichael J Thun
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Jul 7, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E J DuellP Boffetta
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Nov 2, 2013·Pancreas·Claudio PelucchiCarlo La Vecchia
Sep 11, 2014·The New England Journal of Medicine·David P RyanNabeel Bardeesy
Oct 16, 2015·Alcoholism, Clinical and Experimental Research·Alexandra T K LeeMinoti V Apte
Apr 5, 2017·Journal of the National Cancer Institute·Ahmedin JemalHannah K Weir
Jun 13, 2017·International Journal of Epidemiology·Anne-Marie BouvierUNKNOWN French Network of Cancer Registries (FRANCIM)
Jun 24, 2017·International Journal of Epidemiology·R L MilneG G Giles
Oct 11, 2017·Gut·Faiyaz NottaFrancisco X Real
Oct 13, 2017·International Journal of Epidemiology·Louis Buscail
Nov 8, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noelle K LoConteAnthony J Alberg
Nov 23, 2017·Lancet· The Lancet
Mar 11, 2018·International Journal of Cancer. Journal International Du Cancer·Sabine NaudinPietro Ferrari
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E J DuellP Boffetta

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.